About Us

CYBERnano is a start-up founded in 2013 specialized in Data Science and Risk Assessment for BioPharma. Inspired by biologists’ needs and a sound experience in Quality-by-Design in Nanomedicine, CYBERnano has developed 2 innovative activities: 


  • i-QbD : supervized platform of services to easily implement the Quality-By-Design best practices to speed up the development of innovative Drugs and Medical Devices;

  • BiologIA : development of tailor-made SaaS platforms & software to automate the analysis of biological data. 

We use data analysis in ways that move science forward

in the fields of Nanomedicine and Medical Devices.